Low-dose aspirin as treatment for central serous chorioretinopathy
Antonio Caccavale1, Filippo Romanazzi1, Manuela Imparato1, Angelo Negri1, Anna Morano2, Fabio Ferentini11Department of Ophthalmology, Hospital C Cantù, Abbiategrasso, Milan; 2University Eye Clinic, Foundation IRCCS San Matteo Hospital, Pavia, ItalyPurpose: To evaluate the effectivenes...
Guardado en:
Autores principales: | Antonio Caccavale, Filippo Romanazzi, Manuela Imparato, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df09e4699ca4414d864fbdb0844326de |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Central serous chorioretinopathy: a pathogenetic model
por: et al, et al.
Publicado: (2011) -
Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon M, et al.
Publicado: (2013) -
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
por: Karim SP, et al.
Publicado: (2013) -
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin Z, et al.
Publicado: (2014) -
Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak T, et al.
Publicado: (2015)